Related Experiment Videos
Cardiac hypertrophy: sorting out the circuitry
1Department of Molecular Biology and Oncology University of Texas Southwestern Medical Center at Dallas, 75235-9148, USA.
Insights
Cardiac hypertrophy, an enlarged heart, initially compensates for reduced output but can lead to heart failure. Key signaling pathways regulate this adaptive response.
Area of Science:
- Cardiology
- Molecular Biology
- Cellular Physiology
Background:
- Cardiac hypertrophy is the heart's adaptive enlargement in response to stimuli.
- While initially compensatory, sustained hypertrophy can lead to heart failure.
- This process involves intricate intracellular signaling and transcription factor activation.
Purpose of the Study:
- To summarize recent advancements in understanding cardiac hypertrophy regulation.
- To highlight key signaling pathways involved in the hypertrophic program.
Main Methods:
- Literature review of recent findings in cardiac hypertrophy research.
- Analysis of signaling pathways including G proteins, MAP kinases, and calcium-responsive phosphatases.
Main Results:
- Identification of G proteins, MAP kinases, and calcium-responsive phosphatases as critical regulators.
- Understanding the coupling of signal transduction to transcription factors.
Conclusions:
- Recent research has elucidated the critical role of specific signaling pathways in cardiac hypertrophy.
- Further understanding of these pathways is crucial for managing heart conditions.
Abstract:
Cardiac hypertrophy is an adaptive response of the heart to a variety of intrinsic and extrinsic stimuli. The hypertrophic response, during which cardiomyocytes increase in size without undergoing cell division, initially serves to compensate for decreased cardiac output; however, prolonged hypertrophy can become detrimental, resulting in dilated cardiomyopathy and heart failure. Cardiac hypertrophy requires coupling of intracellular signal transduction systems with transcription factors that activate and maintain the hypertrophic program. Over the past year, signaling pathways involving G proteins, mitogen-activated protein kinases and calcium-responsive phosphatases have emerged as critical regulators of cardiac hypertrophy.